Related Experiment Video
Updated: Jan 8, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
A Novel Case of Robotic Retroperitoneal Lymph Node Dissection for Metastatic Sertoli Cell Tumour: A Case Report
Pranav Patel1, Stuart Henderson2, Kamran Haq2
1Surgery, Southampton General Hospital NHS Foundation Trust, Southampton, GBR.
Abstract:
Sertoli cell tumours of the testes (SCTT) are a rare subgroup of sex cord stromal tumours. This report describes a novel use of robotic retroperitoneal lymph node dissection (RPLND) in a rare case of metastatic disease that posed significant diagnostic challenges. A 60-year-old male presented with a left testicular mass; post-orchidectomy histological review confirmed high-risk Sertoli cell tumour. A subsequent PET-CT identified metastatic para-aortic lymph nodes; an incidental finding of a non-functioning paraganglioma was also noted. The patient underwent a successful robotic RPLND, performed using the DaVinci Xi robotic platform. Postoperative recovery was uneventful, and the patient was discharged on postoperative day two. Histology confirmed metastasis in two out of 10 lymph nodes. This report highlights the potential of robotic RPLND as a viable treatment course, with its success emphasising the critical role of multidisciplinary team collaboration. While we describe a novel approach, further studies and long-term oncological outcomes in larger patient cohorts are necessary to establish definitive treatment guidelines.

